Six rising stars at Scotland's largest vaccine manufacturer, Valneva Scotland, have embarked on an emerging leaders programme, equipping them with skills for life and helping unlock their full ...

Boehringer Ingelheim and Cue Biopharma, Inc. (Nasdaq: CUE) today announced a strategic research collaboration and license agreement to develop and commercialize Cue Biopharma’s CUE-501 product ...

Viatris Inc. (Nasdaq: VTRS) today announced that Hemanth J. Varghese has joined the Company as Chief Strategy Officer. Varghese will be a member of the Company's Executive Leadership Team. Varghese is ...

A new, mid-size Contract Development Manufacturing Organisation (CDMO), Meribel Pharma Solutions has launched today with an extensive integrated network across Europe, led by a team of industry ...

Galapagos NV (Euronext & NASDAQ: GLPG), a global biotechnology company dedicated to transforming patient outcomes through life-changing science and innovation, today announced the departure of its CFO ...

Astraveus SAS (“Astraveus” or the “Company”), the Benchtop Cell Factory company, today announces that it has strengthened its leadership team and Board of Directors with three experienced hires.

Sanofi today shared new progress from its mid- to late-stage respiratory pipeline, including preliminary phase 2 results for amlitelimab in adults with moderate-to-severe asthma.

The Global Cosmetic Surgery Market achieved a valuation of $60.22 Billion in 2024 and is anticipated to exceed $136.55 Billion by 2035, reflecting a compounded annual growth rate (CAGR) of 7.75% ...

The Global Single Cell Analysis Market achieved a valuation of $4.90 Billion in 2024 and is anticipated to exceed $21.97 Billion by 2035, reflecting a compounded annual growth rate (CAGR) of 16.55% ...

The Global Breast Pump Market achieved a valuation of $3.23 Billion in 2024 and is anticipated to exceed $8.12 Billion by 2035, reflecting a compounded annual growth rate (CAGR) of 8.75% during the ...

The Global Breast Imaging Market achieved a valuation of $5.68 Billion in 2024 and is anticipated to exceed $15.86 Billion by 2035, reflecting a compounded annual growth rate (CAGR) of 9.85% during ...

The global Veterinary Software Market is valued at USD 1.44 Billion in 2024 and is projected to reach a value of USD 5.91 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 13.75% between 2025 ...